LTUS OTC
Lotus Pharmaceuticals, Inc.
1W: +8.4%
1M: +46.3%
3M: +41.6%
YTD: +46.3%
1Y: +29.1%
3Y: -26.8%
5Y: -87.8%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
+0.0% YoY
$-0M
Net Income
+11.8% YoY
$-0M
Free Cash Flow
+24.0% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE14.7%
ROA-404.6%
ROIC-340.1%
Valuation
P/E-385.1
P/B0.0
EV/EBITDA-653.2
Leverage
Debt/Equity-1.04
Current Ratio0.03
Interest Cov.0.0x
Quality Scores
Piotroski F3/9
Altman Z-10932.35
Beneish M0.00